(Q34978326)

5 August 2017

1 reference

title

Immunoprophylaxis against important virus disease of horses, farm animals and birds (English)

1 reference

5 August 2017

Patel JR

1

1 reference

PubMed ID

19402200

5 August 2017

Heldens JG

series ordinal

2

1 reference

PubMed ID

19402200

5 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

5 August 2017

1 reference

5 August 2017

27

1 reference

5 August 2017

12

1 reference

5 August 2017

1797-1810

1 reference

Edward Jenner and the history of smallpox and vaccination

5 August 2017

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

7 January 2021

inferred from DOI database lookup

Veterinary vaccine development from an industrial perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Global FMD control--is it an option?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Vaccination against equine influenza: quid novi?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Field Studies on Equine Influenza Vaccination Regimes in Thoroughbred Foals and Yearlings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Derivation and characterization of a live attenuated equine influenza vaccine virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Boosting in equine influenza vaccination schedules: timing and time for a re-evaluation of requirements of national and international authorities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

African horse sickness in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Diagnostic methods for African horsesickness virus using monoclonal antibodies to structural and non-structural proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Evaluation of a quadrivalent inactivated vaccine for the protection of cattle against diseases due to common viral infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Characteristics of live bovine herpesvirus-1 vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Evaluation of efficacy of an inactivated vaccine against bovine respiratory syncytial virus in calves with maternal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Benefits and risks of antibody and vaccine production in transgenic plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

7 January 2021

Foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

The duration of immunity in cattle following inoculation of rinderpest cell culture vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

A single vaccine for the control of capripox infection in sheep and goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication-deficient vaccine vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Round table on epidemiology and control of fox rabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Molecular biology of pseudorabies (Aujeszky's disease) virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Role of different genes in the virulence and pathogenesis of Aujeszky's disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Construction and characterization of deletion mutants of pseudorabies virus: a new generation of 'live' vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Round table on control of Aujeszky's disease and vaccine development based on molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Oral immunisation of swine with a classical swine fever vaccine (Chinese strain) and transmission studies in rabbits and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Experimental reproduction of porcine epidemic abortion and respiratory syndrome (mystery swine disease) by infection with Lelystad virus: Koch's postulates fulfilled

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Approaches to the identification of non-essential genes of African swine fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Survey of infectious agents involved in acute respiratory disease in finishing pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Porcine circoviruses: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Immunologic features of porcine circovirus type 2 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Immunogenicity of empty capsids of porcine circovius type 2 produced in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Potential new Culicoides vector of bluetongue virus in northern Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Evidence for transplacental and contact transmission of bluetongue virus in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

From genes to complex structures of bluetongue virus and their efficacy as vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

The challenge of avian influenza to the veterinary community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Reference viruses for seasonal and pandemic influenza vaccine preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

A wild goose metapneumovirus containing a large attachment glycoprotein is avirulent but immunoprotective in domestic turkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Replication kinetics of Marek's disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Marek's disease: an update on oncogenic mechanisms and control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Classification of Marek's disease viruses according to pathotype: philosophy and methodology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Infectious bursal disease of poultry: antigenic structure of the virus and control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Chicken anaemia agent: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Non-replicating expression vectors: applications in vaccine development and gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

New technologies for making vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Current status of flavivirus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Negative-strand RNA viruses: genetic engineering and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Genetic manipulation of non-segmented negative-strand RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Highly stable expression of a foreign gene from rabies virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Alphaviruses--vectors for the expression of heterologous genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

DNA and RNA-based vaccines: principles, progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Applications in in ovo technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Bacterial toxins as mucosal adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Vaccine delivery to animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

7 January 2021

inferred from DOI database lookup

Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.063

7 January 2021

inferred from DOI database lookup

Immunopathogenesis of chicken anemia virus infection

1 reference

12 December 2020

Rationale for the use of influenza vaccines in horses and the importance of antigenic drift

1 reference

12 December 2020

Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes

1 reference

12 December 2020

Replication-defective bovine adenovirus type 3 as an expression vector

1 reference

12 December 2020

Bovine respiratory disease: commercial vaccines currently available in Canada.

1 reference

12 December 2020

Future influenza vaccines and the use of genetic recombinants

1 reference

12 December 2020

Studies on the transmission of African horsesickness

1 reference

12 December 2020

Immune responses of sheep to louping-ill virus vaccine

1 reference

12 December 2020

Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains

1 reference

12 December 2020

A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes

1 reference

12 December 2020

Prospects, including time-frames, for improved foot and mouth disease vaccines.

1 reference

12 December 2020

The safe and effective use of fowlpox virus as a vector for poultry vaccines.

1 reference

12 December 2020

Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease

1 reference

12 December 2020

African swine fever virus. Pathogenesis.

1 reference

12 December 2020

Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus

1 reference

12 December 2020

Financial evaluation of vaccination and testing alternatives for control of parvovirus-induced reproductive failure in swine

1 reference

12 December 2020

Prospects for development of a vaccine against the West Nile virus

1 reference

12 December 2020

10.1016/J.VACCINE.2008.12.063

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

19402200